Alligator Bioscience
1.074 SEK -3.76%3 investors are following this company
Alligator Bioscience is a research-based biotechnology company that uses patented technology to develop biological drug candidates in inflammation and cancer. The company is active in the former part of the drug development chain. Alligator Bioscience has a global technology platform and is active in a rapidly growing segment of the pharmaceutical market - protein drugs. The company was founded in 2001 and is headquartered in Lund, Sweden.
Revenue
58.11M
EBIT %
-428.46 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
ATORX
Daily low / high price
1.042 / 1.122
SEK
Market cap
815.15M SEK
Turnover
2.98M SEK
Volume
2.8M
Latest videos
Financial calendar
Interim report
2024-07-11
Interim report
2024-10-24
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Allegro Investment | 32.9 % | 33.0 % |
Roxette Photo | 7.0 % | 7.1 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Alligator Bioscience Announces Substantial Overall Survival Benefit and Unprecedented Duration of Response in the 18-Month Analysis from Mitazalimab OPTIMIZE-1 Phase 2 Study in 1st Line Pancreatic Cancer
Alligator Bioscience offentliggör finansiering om upp till 80 MSEK som förlänger kassalikviditet till Q1 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools